# Comparison of Arterolane-piperaquine Versus Arterolane-piperaquine+Mefloquine Versus Artemether-lumefantrine in Kenyan Children

> **NCT03452475** · PHASE3 · COMPLETED · sponsor: **University of Oxford** · enrollment: 219 (actual)

## Conditions studied

- Plasmodium Falciparum

## Interventions

- **DRUG:** Arterolane-piperaquine
- **DRUG:** Arterolane-piperaquine+mefloquine
- **DRUG:** Artemether-lumefantrine

## Key facts

- **NCT ID:** NCT03452475
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-07
- **Primary completion:** 2019-06-03
- **Final completion:** 2019-06-03
- **Target enrollment:** 219 (ACTUAL)
- **Last updated:** 2021-09-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03452475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03452475, "Comparison of Arterolane-piperaquine Versus Arterolane-piperaquine+Mefloquine Versus Artemether-lumefantrine in Kenyan Children". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03452475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*